|
female |
10 |
|
humans |
10 |
|
adrenomedullin - genetics - metabolism |
8 |
|
calcitonin receptor-like protein |
8 |
|
cell communication - physiology |
8 |
|
cell line |
8 |
|
cilia - metabolism - physiology |
8 |
|
epithelium - metabolism - physiology |
8 |
|
fallopian tubes - metabolism |
8 |
|
gene expression regulation - drug effects |
8 |
|
hormones - metabolism - pharmacology |
8 |
|
intracellular signaling peptides and proteins - genetics - metabolism |
8 |
|
male |
8 |
|
membrane proteins - genetics - metabolism |
8 |
|
menstrual cycle - genetics - metabolism - physiology |
8 |
|
models, biological |
8 |
|
receptor activity-modifying proteins |
8 |
|
receptors, calcitonin - genetics - metabolism |
8 |
|
spermatozoa - metabolism - physiology |
8 |
|
adrenomedullin |
7 |
|
ciliary beat frequency |
7 |
|
nasal ciliated epithelium |
7 |
|
polycystic ovary syndrome |
7 |
|
spermatozoa |
7 |
|
tubal ectopic pregnancy |
7 |
|
apoptosis |
6 |
|
biological markers - blood |
6 |
|
dysglycaemia |
6 |
|
fasting glucose |
6 |
|
leptin |
6 |
|
leptin receptor |
6 |
|
letrozole |
6 |
|
medical abortion |
6 |
|
mifepristone |
6 |
|
misoprostol |
6 |
|
oral glucose tolerance test |
6 |
|
progesterone receptor |
6 |
|
ulipristal acetate |
6 |
|
anti-mullerian hormone |
5 |
|
antral follicle count |
5 |
|
endometrial attachment |
5 |
|
ishikawa cell line |
5 |
|
primary endometrial cell culture |
5 |
|
abortifacient agents, nonsteroidal - pharmacokinetics |
4 |
|
abortion, induced - methods |
4 |
|
acetic acid |
4 |
|
acetic acid - pharmacokinetics |
4 |
|
acrosome reaction |
4 |
|
acrosome reaction - drug effects - physiology |
4 |
|
adolescent |
4 |
|
adult |
4 |
|
age |
4 |
|
anti-mullerian hormone - analysis - blood |
4 |
|
anti-mullerian hormone - blood |
4 |
|
anti-müllerian hormone |
4 |
|
antimullerian hormone |
4 |
|
capacitation |
4 |
|
cell count |
4 |
|
chlortetracycline - metabolism - pharmacology |
4 |
|
combined injectable contraceptive |
4 |
|
combined oral contraceptive |
4 |
|
contraceptives, oral, combined - pharmacology |
4 |
|
controlled ovarian stimulation |
4 |
|
cumulative live birth |
4 |
|
cumulative live-birth |
4 |
|
fertilization |
4 |
|
frozen-thawed embryo transfer |
4 |
|
hydrogen-ion concentration |
4 |
|
hyperprolactinemia |
4 |
|
hypogonadotrophic hypogonadism |
4 |
|
in-vitro fertilisation |
4 |
|
infertility - blood - diagnosis - therapy |
4 |
|
inhibin b |
4 |
|
inhibins - blood |
4 |
|
insemination, artificial - methods |
4 |
|
intrauterine devices, medicated |
4 |
|
intrauterine insemination |
4 |
|
intrauterine lidocaine |
4 |
|
isolated polycystic ovaries |
4 |
|
leptin - metabolism - pharmacology |
4 |
|
levonorgestrel intrauterine system |
4 |
|
lidocaine gel |
4 |
|
live birth |
4 |
|
live-birth |
4 |
|
luteal phase support |
4 |
|
middle aged |
4 |
|
misoprostol - pharmacokinetics |
4 |
|
motility |
4 |
|
natural cycles |
4 |
|
normal saline |
4 |
|
oligomenorrhea - blood - diagnosis - etiology |
4 |
|
ovarian response prediction index |
4 |
|
ovulation induction - adverse effects - methods |
4 |
|
pain relief |
4 |
|
pharmacokinetics |
4 |
|
pregnancy rate |
4 |
|
premature ovarian failure |
4 |
|
progesterone |
4 |
|
progestins - pharmacology |
4 |
|
progestogen-only injectable |
4 |
|
progestogen-only pill |
4 |
|
prospective studies |
4 |
|
saline contrast sonohysterography |
4 |
|
saline infusion sonogram |
4 |
|
semen - metabolism |
4 |
|
sperm capacitation - drug effects |
4 |
|
sperm motility - drug effects - physiology |
4 |
|
spermatozoa - drug effects - metabolism - physiology |
4 |
|
vaginal misoprostol |
4 |
|
adrenomedullin - blood - genetics - physiology |
3 |
|
cilia - physiology |
3 |
|
emergency contraception |
3 |
|
fallopian tubes - physiology |
3 |
|
menstrual pattern |
3 |
|
post-ovulatory |
3 |
|
pre-ovulatory |
3 |
|
pregnancy |
3 |
|
pregnancy, tubal - blood - etiology - physiopathology |
3 |
|
caesarean scar |
2 |
|
choriocarcinoma |
2 |
|
choriocarcinoma - metabolism |
2 |
|
ectopic pregnancy |
2 |
|
fertilization in vitro |
2 |
|
hydatidiform mole |
2 |
|
hydatidiform mole - metabolism |
2 |
|
immunohistochemistry |
2 |
|
ivf |
2 |
|
leptin - biosynthesis |
2 |
|
obstetric outcomes |
2 |
|
pcos |
2 |
|
placenta - metabolism |
2 |
|
placental site trophoblastic tumor |
2 |
|
protein isoforms |
2 |
|
receptors, cell surface - biosynthesis |
2 |
|
receptors, leptin |
2 |
|
reverse transcriptase polymerase chain reaction |
2 |
|
up-regulation |
2 |
|
uterine neoplasms - metabolism |
2 |
|
abortion |
1 |
|
adipocyte |
1 |
|
administration, intravaginal |
1 |
|
anesthetics, local - administration & dosage |
1 |
|
anovulation - drug therapy |
1 |
|
anovulatory subfertility |
1 |
|
assisted conception |
1 |
|
beta-adrenergic receptor signaling |
1 |
|
biopsy, needle - adverse effects |
1 |
|
case-control studies |
1 |
|
cervical punch biopsy |
1 |
|
colposcopy |
1 |
|
colposcopy - adverse effects |
1 |
|
cumulative ongoing pregnancy |
1 |
|
double-blind method |
1 |
|
family planning services |
1 |
|
follicle stimulating hormone, human - therapeutic use |
1 |
|
gels |
1 |
|
gonadotrophin |
1 |
|
health services accessibility |
1 |
|
hyperandrogenism - blood - complications - epidemiology |
1 |
|
induced |
1 |
|
infertility, female - drug therapy |
1 |
|
lidocaine - administration & dosage |
1 |
|
lipogenesis |
1 |
|
lipolysis |
1 |
|
long-acting reversible contraception |
1 |
|
medical sciences |
1 |
|
metabolic syndrome x - blood - epidemiology - etiology |
1 |
|
npy |
1 |
|
obesity - blood - complications - epidemiology |
1 |
|
obstetrics and gynecology |
1 |
|
ovarian response |
1 |
|
ovulation induction |
1 |
|
ovulation induction - methods |
1 |
|
pain - prevention & control |
1 |
|
pain measurement |
1 |
|
pilot projects |
1 |
|
polycystic ovary syndrome - blood - complications - epidemiology |
1 |
|
prevalence |
1 |
|
retrospective studies |
1 |
|
risk factors |
1 |
|
scotland - epidemiology |
1 |
|
topical xylocaine gel |
1 |
|
vitamin d - analogs & derivatives - blood |
1 |
|
vitamin d deficiency - blood - complications - epidemiology |
1 |
|
young adult |
1 |
